Clinical Evaluation of the Bioavailability of Zinc-enriched Yeast and Zinc Gluconate in Healthy Volunteers
- 317 Downloads
Zinc (Zn)-enriched yeast and gluconate are considered two of the more biologically available supplements. However, there have been few reports comparing the bioavailability of these supplements. The objective of this study was to demonstrate whether Zn was absorbed better by healthy male volunteers when given supplements where the mineral is found organically bound in yeast or as a salt gluconate form. The trial used a randomized, two-way crossover design. Urine, blood, and fecal samples were collected and analyzed over a 48-h period after a single dose of supplement. The net Zn balance and the relative bioavailability were calculated. No differences were observed in urine excretion of the two supplements. Zinc gluconate gave higher Zn concentrations in the blood in the first 6 h but also showed greater losses in the feces. Zinc yeast also increased in blood with time but showed significantly less loss in the feces. Thus, the net Zn balance after 48 h for Zn yeast was 9.46 but for Zn gluconate it was −2.00, indicating that Zn gluconate supplementation contributed to a net loss of Zn. It was concluded that organic Zn yeast supplements are more biologically available than Zn gluconate salts.
KeywordsZinc gluconate Zinc-enriched yeast Bioavailability Zinc absorption
The authors wish to gratefully acknowledge the technical support staff from the Medical Corporation LTA (Souseikai Osaki Clinic); B. M. L. Association; and Japan Food Research Laboratories and Sogo Clinical Pharmacology Co., Ltd. In addition, they wish to acknowledge the financial support of Lallemand Inc. (Montreal, Canada) and Space-H Enterprise Ltd. (Tokyo, Japan).
- 4.Hughes S, Samman S (2006) The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis. J Am Coll Nutr 24:285–291Google Scholar
- 5.Beletate V, El Dib R, Atallah A (2007) Zinc supplementation for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev 24:CD005525Google Scholar
- 6.Salgueiro MJ, Zubillaga MB, Lysionek AE, Sarabia MI, Caro RA, De Paoli T, Hager A, Ettlin E, Weill R, Boccio JR (2000) Bioavailability, biodistribution, and toxicity of BioZn-AAS; a new zinc source, comparative studies in rats. Nutrition 16:7623–766Google Scholar
- 8.Vinson JA, Tompkins TA, Agbor GA (2007) Comparative bioavailability of mineral enriched gluconates and yeasts in rat liver following depletion–repletion feeding. Biol Trace Elem Res (in press)Google Scholar
- 9.Vinson JA, Bose P, Lemoine L, Hsiao KH (1989) Comparative human bioavailability of zinc. In: Southgate D, Johnson I, Fenwick GR (eds) Nutrient availability: chemical and biological aspects. Royal Society of Chemistry Publications, Cambridge, England, pp 125–127Google Scholar
- 12.Spencer H, Kramer L, Osis D (1982) Zinc balances in humans. In: Prasad AS (ed) Clinical, biochemical and nutritional aspects of trace elements. Alan R. Liss, New York, NY, pp 103–115Google Scholar